 | Up a level |
Maas, O; Forrer, F; Maas, M; Panje, C. M.; Blautzik, J; Brühlmeier, M; Engel-Bicik, I; Giovanella, L; Haldemann, A; Kamel, M E; Kneifel, S; Rottenburger, C; Schaefer, N; Walter, M A; Weidner, Sabine; Putora, Paul Martin (2020). Variations in radioiodine ablation: decision-making after total thyroidectomy. European journal of nuclear medicine and molecular imaging, 47(3), pp. 554-560. Springer-Verlag 10.1007/s00259-019-04557-4
Cordier, D; Forrer, F; Bruchertseifer, F; Morgenstern, A; Apostolidis, C; Good, S; Müller-Brand, J; Mäcke, H; Reubi, J C; Merlo, A (2010). Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial. European journal of nuclear medicine and molecular imaging, 37(7), pp. 1335-44. Berlin: Springer 10.1007/s00259-010-1385-5
Melis, M; Forrer, F; Capello, A; Bijster, M; Bernard, B F; Reubi, J C; Krenning, E P; De Jong, M (2007). Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [(177)Lu-DOTA(0),Tyr(3)]octreotate therapy. Quarterly journal of nuclear medicine and molecular imaging, 51(4), pp. 324-33. Torino: Minerva Medica
